BERLIN-CHEMIE: A woman heading the German business

Christiane von der Eltz was appointed to the Executive Board of BERLIN-CHEMIE on June 1 of this year and is responsible for the Pharma Germany division. The qualified pharmacist brings with her a wealth of experience in the pharmaceutical industry.…

More

More than the cheese of the future – Formo wants to create sustainability with biotech

The start-up Formo is a food biotech company that uses biotechnological processes to develop proteins for the food of the future. We spoke to Sandra Wilde, Formo’s Head of Food Science, about the current development status of the company and their…

More

Replace, Reduce, Refine – More ethics in animal testing for tomorrow’s medicine

Interview with: Prof. Jens Kurreck, TU Berlin and Director of the 3R Center Berlin

More

Interview with: Prof. Georg N. Duda and Bianca Lemke, Charité and cooperation partner Dr. Lutz Kloke, Cellbricks

Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…

More

Dr. Lutz Hilbrich, Chief Executive Officer at ProBioGen (and the subsidiary MiGenTra) and Andrea Hauptmann, Chief Financial Officer at ProBioGen (and the subsidiary MiGenTra)

ProBioGen was founded in Berlin in 1994, and has been part of the Egyptian Minapharm Group since 2010. The biotech company and its subsidiary MiGenTra operate around the globe and have years of experience developing and producing biopharmaceuticals…

More

Interview with Jasper Emeis, research associate of the GrOwnValve project

GrownValve is a spin-off of the Deutsches Herzzentrum Berlin and Charité. The company was founded in 2019. It develops patient-specific, endogenous heart valves, with a focus on pediatrics. We interview Jasper Emeis, research associate of GrOwnValve…

More

Interview: Questions to Dr. Jörg Heldmann, Managing Director of the Charité subsidiary WHS Foundation GmbH on the World Health Summit

 

 

More

Interview with Björn von Siemens, Co-Founder of caresyntax

Björn von Siemens is co-founder and managing director of caresyntax GmbH. The company develops algorithms that analyze risk factors during surgery and provide decision support. The company, based in Berlin and Boston, recently raised 100 million US…

More

Chairman of the Board of Directors of the Berlin Institute of Health (BIH) Professor Christopher Baum

The current pandemic has shown very clearly how important it is to translate medical research results into practice. Promoting this process of translation is the task of the Berlin Institute of Health (BIH), which was integrated into the Charité last…

More

"Germany has done nothing better than other countries, it just acted earlier.”

Double interview with Prof. Dr. Christian Drosten, Director of the Institute of Virology at Charité Berlin and speaker at the World Health Summit, and Prof. Dr. Detlev Ganten, President and Founder of the World Health Summit.

More
Show more items